Trial Results Could Shuffle Order of BTK Inhibitors for CLL/SLL

(MedPage Today) — ORLANDO — In a phase III trial with potential practice-changing implications, the non-covalent Bruton’s tyrosine kinase (BTK) inhibitor pirtobrutinib (Jaypirca) induced a higher response rate in chronic lymphocytic leukemia…

Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118892

Author :

Publish date : 2025-12-08 19:40:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Trial Results Could Shuffle Order of BTK Inhibitors for CLL/SLL

Drug Combo Shows Benefits in Fit Patients With Acute Myeloid Leukemia

New Device Uses Steam to Kill Prostate Cancer

Related Posts

New Device Uses Steam to Kill Prostate Cancer

Drug Combo Shows Benefits in Fit Patients With Acute Myeloid Leukemia

Many Patients Still Face GP Referral ‘Black Hole’

Adding Procedures, Cutting the Paperwork

CDC Panel Targets Size of Childhood Vaccine Schedule, Safety of Aluminum Adjuvants

How worried should you be about screentime?

New Device Uses Steam to Kill Prostate Cancer

Trial Results Could Shuffle Order of BTK Inhibitors for CLL/SLL

Drug Combo Shows Benefits in Fit Patients With Acute Myeloid Leukemia

Many Patients Still Face GP Referral ‘Black Hole’

Adding Procedures, Cutting the Paperwork

CDC Panel Targets Size of Childhood Vaccine Schedule, Safety of Aluminum Adjuvants

How worried should you be about screentime?

Experts Evaluate Aging and Hematologic Disease at ASH

Categories

Archives